Review
Published on 13 Feb 2026
Polydatin in respiratory diseases: multi-target mechanisms and therapeutic potential
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2026.1752467
- 328 views
Type at least 3 characters
682 articles
articles
Review
Published on 12 Feb 2026
Inhibiting the pathological changes of PASMCs is an effective approach for medicinal plants or secondary metabolites in treating pulmonary hypertension
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2026.1725809
- 238 views
Original Research
Published on 11 Feb 2026
LYVE-1 identifies asthma and drives PDGF-BB-induced proliferation, migration, and oxidative stress in airway smooth muscle cells via the PI3K/Akt pathway
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2026.1738301
- 291 views
Original Research
Accepted on 09 Feb 2026
Network toxicology reveals key genes of amiodarone induced pulmonary fibrosis: based on machine learning and SHAP analysis
in Respiratory Pharmacology
Frontiers in Pharmacology
Original Research
Accepted on 04 Feb 2026
Prediction of Site-Specific Drug Deposition via Dry Powder Inhaler using Non-Invasive Real-Time Particle Emission Signal Monitoring System
in Respiratory Pharmacology
Frontiers in Pharmacology
- 214 views
Original Research
Published on 03 Feb 2026
PPAR-gamma regulates PFAS-mediated proinflammatory cytokines in lung epithelial cells
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2026.1779345
- 520 views
Original Research
Published on 03 Feb 2026
Divergent roles of serum CXCL9 as a biomarker in ILD and COPD: a comparative study
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2026.1730688
- 490 views
Original Research
Published on 30 Jan 2026
Tezepelumab in severe asthma: chest computed tomography assessment of airway remodeling and clinical remission
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2026.1757754
- 734 views
Original Research
Accepted on 28 Jan 2026
Beyond codeine – the evidence landscape of conventional, natural, and emerging antitussive therapies: a systematic review and meta-analysis
in Respiratory Pharmacology
Frontiers in Pharmacology
- 127 views
Original Research
Published on 27 Jan 2026
GTX-11 attenuates lung fibrosis, inflammation and vascular remodeling in preclinical models of lung fibrotic disease
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1671132
- 882 views
Original Research
Published on 19 Jan 2026
Long-term nitric oxide exposure induces cough hypersensitivity via non-inflammatory activation of the HIF1α–TRPV1 pathway
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2026.1679727
- 720 views
Case Report
Published on 08 Jan 2026
Case Report: Furmonertinib-induced acute interstitial lung disease
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1742670
- 838 views
Clinical Trial
Published on 07 Jan 2026
Dezocine and butorphanol for the prevention of sufentanil-induced cough: a randomized controlled trial investigating the impact of intravenous access site
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1690090
- 634 views
Original Research
Published on 05 Jan 2026
Lauric acid modulates the cyclooxygenases and nitric oxide pathways and reduces oxidative stress in preventing tracheal hyperresponsiveness in asthmatic Wistar rats
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1657799
- 3,387 views
Review
Published on 05 Jan 2026
Signaling pathways of marine-derived natural products on lung injury: from the in vivo perspective
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1716898
- 708 views
Correction
Published on 03 Dec 2025
Correction: The role of TGF-β1 in chronic multilobar segmental bronchial stenosis and advances in targeted drug research
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1751855
- 543 views
Original Research
Published on 01 Dec 2025
Clinical application of combined anticoagulation therapy in anti-MDA5 antibody-positive associated interstitial lung disease-a retrospective study
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1662306
- 1,100 views
Original Research
Published on 28 Nov 2025
Diacetyl-induced bronchiolitis obliterans involves ubiquitin C upregulation and fibrosis-related gene activation in rats
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1671557
- 1,123 views
Review
Published on 27 Nov 2025
Regulatory mechanisms of luteolin in inflammatory respiratory diseases
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1720824
- 2,459 views
Original Research
Published on 26 Nov 2025
Development and validation of a clinical prediction model for in-hospital mortality of severe pneumonia based on machine learning
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1660893
- 1,162 views
Original Research
Published on 20 Nov 2025
Efficacy and safety of tacrolimus in the treatment of interstitial pneumonia with autoimmune features: a retrospective study
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1721639
- 1,081 views
Review
Published on 19 Nov 2025
Artemisinin and its derivatives: all-rounders that may prevent the progression from lung injury to lung cancer
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1602581
- 4,581 views
Case Report
Published on 14 Nov 2025
Case Report: Telitacicept for interstitial lung disease associated with idiopathic inflammatory myopathies: an observational study
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1647543
- 1,675 views
Original Research
Published on 13 Nov 2025
EGCG alleviates PM2.5-induced lung injury via activation of PPAR-γ to suppress inflammation and oxidative stress
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1695785
- 1,388 views